Endoclear is a pioneering healthcare startup with a mission to reduce hospital infections and enhance endotracheal tube cleaning efficiency. Founded in 2009 by Dr. Brad Vazales, a cardiovascular surgeon from Petoskey, Michigan, the company aims to tackle Hospital Acquired Infections (HAI) with a particular focus on Ventilator Associated Pneumonia (VAP). Additionally, Endoclear seeks to improve the efficiency and effectiveness of endotracheal tube (ETT) cleaning. The startup operates in the Biotechnology, Health Care, and Medical Devices industries. Endoclear's last recorded investment was a $782.79K Venture Round investment on 23 May 2014. No specific information regarding the investors or the headquarters location is available at this time.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $782.79K | - | 23 May 2014 | |
Venture Round | $2.40M | - | 25 Oct 2011 | |
Debt Financing | $500.00K | - | 27 Aug 2011 | |
Venture Round | $1.95M | - | 15 Feb 2010 |
No recent news or press coverage available for Endoclear.